Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
OPXS Optex posts 216 revenue growth to 413M yet stock falls 14 despite strong quarter How Enact ACT talent strategy drives results Enact Posts EPS Beat ASA ASAGold cites strong precious metals market momentum in its recently released quarterly earnings report The key driver behind Amber Intl AMBR revenue growth Q4 2025 EPS Misses Views Wordle 1804 Hints For May 28 NYT Puzzle Maintains Strong Daily Engagement Crude Oil Prices Tumble 6 on USIran Peace Deal Hopes MCX Crude Dips Below 8800 TD Cowen Upgrades Vertiv Price Target on Data Center Demand Outlook Fed Rate Hike Odds Rise as Hot Inflation Report Reshapes Market Expectations Semiconductor Titans Hit 1 Trillion Samsung Ends Strike Micron Surges on AI Valuation CNBC Investment Club Trims Position After 46 Weekly Gain and 80 Surge Since April Borr Drilling BORR Q1 2026 Earnings WiderthanExpected Loss as Offshore Market Challenges Persist REYN Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher EVTC Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Revenue Uncertainty NTZ Q4 2011 Earnings Significant EPS Miss as Company Reports WiderthanExpected Loss IMUX Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally ONEOK Q1 2026 Earnings Small EPS Beat Drives Modest Share Gain Alussa Energy Acquisition Corp II ALUB Trading Flat Near NAV SPAC Holds Steady at 1001 Ocugen Inc OCGN Rallies 3 as Biotech Stock Tests Key Resistance Near 145 National Vision Holdings EYE Hovers Near Flat as Stock Tests Key Support Levels ProCap Acquisition Corp Unit PCAPU Holds Steady Near Resistance After Marginal Decline SP Global Inc SPGI Eases 158 as Market Digests Steady Fundamentals uCloudlink Group UCL Q1 2026 Earnings NarrowerThanExpected Loss Fails to Propel Stock Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline YSG Q4 2025 Earnings Strong EPS Performance Lifts Stock Despite Sparse Data Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus i3 Verticals IIIV Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment NMFC Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Unchanged